Protagonist Therapeutics Inc. (PTGX) Slipped -5.66% or -0.39 To Price $6.5 On Thursday


Protagonist Therapeutics Inc. (PTGX) slipped -5.66% or -0.39 to $6.5. It is around 71868 shares traded, which is 64.14% compare to the average total volume 112053. The market cap of PTGX is $157.21 million. The year to date change is -5.66%. The 52 week price range is from $5.49 to $23.97. Price of PTGX have changed 8.16% during last week. It have changed 9.02% over last month, -31.78% over last 3 months, 1.03% over last 6 months and -67.42% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PTGX is 7.57. It is 16.46% above current price. The 200-day Moving Averages for PTGX is 8.58. It is 32.00% above current price. The 52-week High is 23.97. It is 268.77% from the current price. The 52-week Low is 5.49. It is -15.54% from current price.

There are some statistics of PTGX. It is has market cap $157.21 million. The share outstanding is 24.19 million. The average volume is 112053. The percent of top 15 Institution holding is 98.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PTGX is -30.93%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PTGX is -21.68%.


Tags:

Share this post